glp-1 receptors PDB-101: Molecule of the Month: Receptor Agonists GLP-1 Receptor Agonists as Treatments

Serious side effects, including kidney disease, do not happen as often, but they can be very harmful

doi: 10.32471/exp-oncology.2312-8852.vol-44-no-2.18025 152 GastonSMGriswoldAJKryvenkoONGuTZhangG-NPrakashNSet al

Several miRNAs, such as miR-199a, miR-128 and miR-187, bind to the 3UTR region of B7-H3 and regulate its expression ( + T cell activity and facilitated disease progression ( 0 /G 1 phase of the cell cycle ( 5 Mechanism of action and role in cancer Although B7-H3 is not an established cancer biomarker, lately it started to gain importance because of its overexpression in cancer compared to healthy tissues ( Figures 1 , 2

In the future, alternative approaches such as in vitro-in vivo extrapolation (IVIVE) or organ-on-chip (OoC) and integrated toxicokinetic modelling might also be useful

How to Choose the Right GLP-1 Medication for You